Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8 Gets Listing Extension from NYSE Alternext

NEW YORK (GenomeWeb News) – Accelr8 today said that it has received a notice from the NYSE Alternext exchange informing the firm that it has granted a listing extension based on a plan submitted by the firm to regain compliance with listing regulations by July 6, 2010.

The Denver-based assay instrument developer was informed by the Alternext in January that it was not in compliance with certain listing standards concerning its amount of stockholder equity, and that it must submit and implement a plan to regain compliance within 18 months.

Accelr8 said today that it has provided the exchange with a plan to show how it intends to regain compliance with a rule that its stockholders' equity equal or exceed $6 million, and for continuing operations and net income to reverse from losses sustained in its five most recent fiscal years.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.